Literature DB >> 15760617

Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease.

Kurt A Jellinger1, Johannes Attems.   

Abstract

Cerebrovascular lesions in Alzheimer disease (AD) being significantly more frequent than in nondemented elderly subjects suggest overlaps and synergistic effects between both pathologies. Examination of a consecutive series of autopsy-proven AD cases and age-matched controls revealed a higher frequency of vascular lesions and of cerebral amyloid angiopathy (CAA) in AD (57.34% vs. 33.2% and 94.1% vs. 33.3%, respectively). These and previous data on vascular pathology in Parkinson disease emphasize its importance in these disorders. A study comparing the frequency and extent of general CAA and capillary CAA (CapCAA) in the postmortem frontal cortex of cases with high and low Braak stages showed no correlation between general CAA and dementia, only a low one with other vascular lesions except for cerebral hemorrhages. However, it was higher in AD than in controls with vascular pathology. The severity of CapCAA not correlating with general CAA showed high correlation with AD pathology, suggesting different pathogenesis of both types of CAA. Its elucidation may have implications for new therapeutic strategies. Considering the variability of vascular pathology in both AD and aged brains, the mechanisms behind their interactions are largely unknown, and further studies are needed to clarify their impact on cognitive impairment.

Entities:  

Mesh:

Year:  2004        PMID: 15760617     DOI: 10.1016/j.jns.2004.11.018

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  38 in total

1.  Toward a pathological definition of vascular dementia.

Authors:  Lea Tenenholz Grinberg; Helmut Heinsen
Journal:  J Neurol Sci       Date:  2010-12-15       Impact factor: 3.181

2.  Cognitive correlates of white matter lesion load and brain atrophy: the Northern Manhattan Study.

Authors:  Chuanhui Dong; Nooshin Nabizadeh; Michelle Caunca; Ying Kuen Cheung; Tatjana Rundek; Mitchell S V Elkind; Charles DeCarli; Ralph L Sacco; Yaakov Stern; Clinton B Wright
Journal:  Neurology       Date:  2015-07-08       Impact factor: 9.910

3.  Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA).

Authors:  Zhihao Zha; Seok Rye Choi; Karl Ploessl; Brian P Lieberman; Wenchao Qu; Franz Hefti; Mark Mintun; Daniel Skovronsky; Hank F Kung
Journal:  J Med Chem       Date:  2011-11-09       Impact factor: 7.446

4.  Chronic Hypertension Leads to Neurodegeneration in the TgSwDI Mouse Model of Alzheimer's Disease.

Authors:  Anna Kruyer; Nadine Soplop; Sidney Strickland; Erin H Norris
Journal:  Hypertension       Date:  2015-05-04       Impact factor: 10.190

Review 5.  Atypical Clinical Manifestations of Cerebral Amyloid Angiopathy.

Authors:  Carolyn Akers; Lealani May Y Acosta; Ciaran Considine; Daniel Claassen; Howard Kirshner; Matthew Schrag
Journal:  Curr Neurol Neurosci Rep       Date:  2019-07-27       Impact factor: 5.081

Review 6.  Alzheimer's disease, brain immune privilege and memory: a hypothesis.

Authors:  Y I Arshavsky
Journal:  J Neural Transm (Vienna)       Date:  2006-08-24       Impact factor: 3.575

7.  Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice.

Authors:  Jing Yang; Yong Ji; Pankaj Mehta; Kristyn A Bates; Yanjie Sun; Thomas Wisniewski
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 8.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

Review 9.  Contribution of hypoxia to Alzheimer's disease: is HIF-1alpha a mediator of neurodegeneration?

Authors:  O O Ogunshola; X Antoniou
Journal:  Cell Mol Life Sci       Date:  2009-09-11       Impact factor: 9.261

Review 10.  Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review.

Authors:  Hannah A D Keage; Roxanna O Carare; Robert P Friedland; Paul G Ince; Seth Love; James A Nicoll; Stephen B Wharton; Roy O Weller; Carol Brayne
Journal:  BMC Neurol       Date:  2009-01-13       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.